Compile Data Set for Download or QSAR
Report error Found 82 Enz. Inhib. hit(s) with all data for entry = 13263
TargetComplement receptor type 1/B/D(Human)
Novartis Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 772103BDBM772103(US20250289804, Example 51)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
1/3/2026
Entry Details
US Patent

TargetComplement receptor type 1/B/D(Human)
Novartis Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 772102BDBM772102(US20250289804, Example 50)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
1/3/2026
Entry Details
US Patent

TargetComplement receptor type 1/B/D(Human)
Novartis Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 772105BDBM772105(US20250289804, Example 53)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
1/3/2026
Entry Details
US Patent

TargetComplement receptor type 1/B/D(Human)
Novartis Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 772104BDBM772104(Preparation of 4-((2R,4s,6S)-2-cyano-7-((5-methoxy...)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
1/3/2026
Entry Details
US Patent

TargetComplement receptor type 1/B/D(Human)
Novartis Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 772107BDBM772107(US20250289804, Example 55)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
1/3/2026
Entry Details
US Patent

TargetComplement receptor type 1/B/D(Human)
Novartis Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 772106BDBM772106(US20250289804, Example 54)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
1/3/2026
Entry Details
US Patent

TargetComplement receptor type 1/B/D(Human)
Novartis Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 772109BDBM772109(US20250289804, Example 57)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
1/3/2026
Entry Details
US Patent

TargetComplement receptor type 1/B/D(Human)
Novartis Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 772108BDBM772108(US20250289804, Example 56)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
1/3/2026
Entry Details
US Patent

TargetComplement receptor type 1/B/D(Human)
Novartis Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 772111BDBM772111(US20250289804, Example 59)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
1/3/2026
Entry Details
US Patent

TargetComplement receptor type 1/B/D(Human)
Novartis Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 772110BDBM772110(US20250289804, Example 58)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
1/3/2026
Entry Details
US Patent

TargetComplement receptor type 1/B/D(Human)
Novartis Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 772113BDBM772113(US20250289804, Example 61)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
1/3/2026
Entry Details
US Patent

TargetComplement receptor type 1/B/D(Human)
Novartis Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 772115BDBM772115(US20250289804, Example 63)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
1/3/2026
Entry Details
US Patent

TargetComplement receptor type 1/B/D(Human)
Novartis Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 772114BDBM772114(US20250289804, Example 62)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
1/3/2026
Entry Details
US Patent

TargetComplement receptor type 1/B/D(Human)
Novartis Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 772087BDBM772087(Preparation of 4-((5S,7S)-2,2-difluoro-8-((5-metho...)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
1/3/2026
Entry Details
US Patent

TargetComplement receptor type 1/B/D(Human)
Novartis Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 772086BDBM772086(US20250289804, Example 34)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
1/3/2026
Entry Details
US Patent

TargetComplement receptor type 1/B/D(Human)
Novartis Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 772088BDBM772088(US20250289804, Example 36)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
1/3/2026
Entry Details
US Patent

TargetComplement receptor type 1/B/D(Human)
Novartis Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 772093BDBM772093(US20250289804, Example 41)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
1/3/2026
Entry Details
US Patent

TargetComplement receptor type 1/B/D(Human)
Novartis Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 772094BDBM772094(US20250289804, Example 42)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
1/3/2026
Entry Details
US Patent

TargetComplement receptor type 1/B/D(Human)
Novartis Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 772097BDBM772097(US20250289804, Example 45)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
1/3/2026
Entry Details
US Patent

TargetComplement receptor type 1/B/D(Human)
Novartis Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 772096BDBM772096(US20250289804, Example 44)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
1/3/2026
Entry Details
US Patent

TargetComplement receptor type 1/B/D(Human)
Novartis Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 772099BDBM772099(US20250289804, Example 47)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
1/3/2026
Entry Details
US Patent

TargetComplement receptor type 1/B/D(Human)
Novartis Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 772098BDBM772098(US20250289804, Example 46)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
1/3/2026
Entry Details
US Patent

TargetComplement receptor type 1/B/D(Human)
Novartis Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 772101BDBM772101(US20250289804, Example 49)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
1/3/2026
Entry Details
US Patent

TargetComplement receptor type 1/B/D(Human)
Novartis Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 772100BDBM772100(US20250289804, Example 48)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
1/3/2026
Entry Details
US Patent

TargetComplement receptor type 1/B/D(Human)
Novartis Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 772071BDBM772071(US20250289804, Example 18)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
1/3/2026
Entry Details
US Patent

TargetComplement receptor type 1/B/D(Human)
Novartis Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 772135BDBM772135(US20250289804, Example 83)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
1/3/2026
Entry Details
US Patent

TargetComplement receptor type 1/B/D(Human)
Novartis Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 772137BDBM772137(US20250289804, Example 85)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
1/3/2026
Entry Details
US Patent

TargetComplement receptor type 1/B/D(Human)
Novartis Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 772072BDBM772072(US20250289804, Example 19)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
1/3/2026
Entry Details
US Patent

TargetComplement receptor type 1/B/D(Human)
Novartis Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 772075BDBM772075(US20250289804, Example 22)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
1/3/2026
Entry Details
US Patent

TargetComplement receptor type 1/B/D(Human)
Novartis Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 772078BDBM772078(US20250289804, Example 25)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
1/3/2026
Entry Details
US Patent

TargetComplement receptor type 1/B/D(Human)
Novartis Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 772080BDBM772080(Preparation of 4-((2S,4S)-4-(difluoromethoxy)-1-((...)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
1/3/2026
Entry Details
US Patent

TargetComplement receptor type 1/B/D(Human)
Novartis Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 772083BDBM772083(US20250289804, Example 31)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
1/3/2026
Entry Details
US Patent

TargetComplement receptor type 1/B/D(Human)
Novartis Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 772082BDBM772082(US20250289804, Example 30)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
1/3/2026
Entry Details
US Patent

TargetComplement receptor type 1/B/D(Human)
Novartis Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 772084BDBM772084(US20250289804, Example 32)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
1/3/2026
Entry Details
US Patent

TargetComplement receptor type 1/B/D(Human)
Novartis Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 772120BDBM772120(US20250289804, Example 68)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
1/3/2026
Entry Details
US Patent

TargetComplement receptor type 1/B/D(Human)
Novartis Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 772059BDBM772059(US20250289804, Example 4)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
1/3/2026
Entry Details
US Patent

TargetComplement receptor type 1/B/D(Human)
Novartis Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 772123BDBM772123(US20250289804, Example 71)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
1/3/2026
Entry Details
US Patent

TargetComplement receptor type 1/B/D(Human)
Novartis Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 772061BDBM772061(US20250289804, Example 8)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
1/3/2026
Entry Details
US Patent

TargetComplement receptor type 1/B/D(Human)
Novartis Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 772125BDBM772125(US20250289804, Example 73)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
1/3/2026
Entry Details
US Patent

TargetComplement receptor type 1/B/D(Human)
Novartis Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 772060BDBM772060(US20250289804, Example 7)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
1/3/2026
Entry Details
US Patent

TargetComplement receptor type 1/B/D(Human)
Novartis Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 772126BDBM772126(US20250289804, Example 74)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
1/3/2026
Entry Details
US Patent

TargetComplement receptor type 1/B/D(Human)
Novartis Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 772129BDBM772129(US20250289804, Example 77)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
1/3/2026
Entry Details
US Patent

TargetComplement receptor type 1/B/D(Human)
Novartis Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 772128BDBM772128(US20250289804, Example 76)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
1/3/2026
Entry Details
US Patent

TargetComplement receptor type 1/B/D(Human)
Novartis Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 772133BDBM772133(US20250289804, Example 81)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
1/3/2026
Entry Details
US Patent

TargetComplement receptor type 1/B/D(Human)
Novartis Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 772068BDBM772068(US20250289804, Example 15)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
1/3/2026
Entry Details
US Patent

TargetComplement receptor type 1/B/D(Human)
Novartis Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 772070BDBM772070(US20250289804, Example 17)
Affinity DataIC50: 150nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
1/3/2026
Entry Details
US Patent

TargetComplement receptor type 1/B/D(Human)
Novartis Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 772134BDBM772134(US20250289804, Example 82)
Affinity DataIC50: 150nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
1/3/2026
Entry Details
US Patent

TargetComplement receptor type 1/B/D(Human)
Novartis Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 772058BDBM772058(US20250289804, Example 3)
Affinity DataIC50: 150nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
1/3/2026
Entry Details
US Patent

TargetComplement receptor type 1/B/D(Human)
Novartis Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 772077BDBM772077(US20250289804, Example 24)
Affinity DataIC50: 150nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
1/3/2026
Entry Details
US Patent

TargetComplement receptor type 1/B/D(Human)
Novartis Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 772127BDBM772127(US20250289804, Example 75)
Affinity DataIC50: 150nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
1/3/2026
Entry Details
US Patent

Displayed 1 to 50 (of 82 total ) | Next | Last >>
Jump to: